Jan 30 (Reuters) - Bracco Diagnostics Inc:
* BRACCO DIAGNOSTICS INC. RECEIVES U.S. FOOD AND DRUG ADMINISTRATION (FDA) APPROVAL FOR USE OF MULTIHANCEÂ® (GADOBENATE DIMEGLUMINE) INJECTION, 529 MG/ML IN MAGNETIC RESONANCE IMAGING (MRI) OF THE CENTRAL NERVOUS SYSTEM (CNS) IN PEDIATRIC PATIENTS YOUNGER TH Source text for Eikon:
 